Imiquimod, Molluscum, and the Need for a Better “Best Pharmaceuticals for Children” Act
FINANCIAL DISCLOSURE: Dr Katz is a contributor to several of the publications listed in Supplemental Table 1, including VisualDx, Decision Support in Medicine, and Fitzpatrick’s Dermatology in General Medicine. He is a shareholder in Synta Pharmaceuticals Corp. Dr Swetman has indicated she has no financial relationships relevant to this article to disclose.
- Views Icon Views
- Share Icon Share
- Search Site
Kenneth A. Katz, Glenda L. Swetman; Imiquimod, Molluscum, and the Need for a Better “Best Pharmaceuticals for Children” Act. Pediatrics July 2013; 132 (1): 1–3. 10.1542/peds.2013-0116
Download citation file: